RE: 16p14 Oct 2020 16:22
I'll give it a rough go below. But even if you don't like my calculations, doesn't make the rampy ones any more true. I'd like to keep my feet firmly on solid facts.
From the RNS dated 21/09/2020, SYME will have access to the following lines of credit. Not all will necessarily be used by then. Let's assume half is used (change this if you want).
o €4bn by the end of 2021
o €5.5bn end 2022
o €7bn end 2023
o €8bn end 2024
£0.9 to the Euro and at 3% profit to SYME (per the RNS):
2021 - (4000/2x0.9x3%=) £54M
2022 - £75M
2023 - £94.5M
2024 - £108M
From interim statement on 30 June (using last year's figures since this year's were distorted by the RTO), costs of goods sold was 40% of revenue. So EBITDA is 60% of the above:
2021 - £32M
2022 - £45M
2023 - £57M
2024 - £65M
Then there's admin and finance costs on top of that, but these are more fixed. So knock off another million or 2 from the above.
So net profit in 2021 would be something like £30M. Nobody knows what the PE ratio will be, but to get 16p, that would be a PE ratio of 166, which I think is unlikely. If it has a PE ratio of, say 40, that would be £1.2Bn mcap which is 3.5p in about 18 months. A phenomenal return by anyone's standards.